Reuters logo
Dermapharm prepares for listing -Apotheke Adhoc
November 27, 2017 / 10:49 AM / in 19 days

Dermapharm prepares for listing -Apotheke Adhoc

FRANKFURT, Nov 27 (Reuters) - The family behind German generic drugmaker Dermapharm is preparing to take the company public with the help of Morgan Stanley, trade publication Apotheke Adhoc cited people familiar with the matter as saying.

Sources told Reuters in April 2016 that owner Wilhelm Beier had short-listed two financial investors as prospective buyers with one bid reaching about 1.1 billion euros ($1.3 billion) but a deal was never clinched.

Dermapharm and Morgan Stanley declined to comment.

$1 = 0.8381 euros Reporting by Ludwig Burger and Arno Schuetze Editing by Maria Sheahan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below